Case Study Shows That Drug Sensitivity Testing Could Help Personalize Chronic Lymphocytic Leukemia Treatment Selection
PHILADELPHIA (May 26, 2023) — Management of chronic lymphocytic leukemia (CLL) is a rapidly evolving field, so choosing between the growing number of effective, available therapies can be challenging for both physicians and patients.